Clinical Trial: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title:

Brief Summary: The primary objective of the study is to assess the effect of MD1003 on motor and sensory conduction, in patients suffering from demyelinating polyneuropathies.